Please use this identifier to cite or link to this item: http://hdl.handle.net/11455/92190
標題: 利用蛋白質體技術探討人類唾液之口腔癌生物標誌以及抗口腔癌藥物之分子機制
Study on human salivary biomarkers of oral cancer and molecular mechanisms of anti-oral cancer agents using proteomic technology
作者: 周于楨
Yu-Jen Jou
關鍵字: 口腔癌;蛋白質體;生物標識;細胞凋亡;oral cancer;proteomic;biomarker;γ–Bisabolene;apoptosis
引用: 中國中醫藥管理局<中華本草>編委會,《中華本草》。上海科學技術出版社,1999,Vol. 8,pp. 608-612。 Anderson KS, Sibani S, Wallstrom G, et al. Protein microarray signature of autoantibody biomarkers for the early detection of breast cancer. J Proteome Res 2011;10:85–96. Amaral JD, Xavuer JM, Steer CJ, Rodrigues CM. The role of p53 in apoptosis. Discov Med. 2010; 9: 145-152. Ashcroft AE. Protein and peptide identification: the role of mass spectrometry in proteomics. Nat. Prod. Rep. 2003; 20:202-215. Bahar G, Feinmesser R, Shpitzer T, Popovtzer A, Nagler RM. Salivary analysis in oral cancer patients: DNA and protein oxidation, reactive nitrogen species and antioxidant profile. Cancer 2007; 109: 54–59. Baker KH, Feldman JE. Cancers of the head and neck. Cancer Nurs 1987; 10: 293–9. Banerjee S, Sharma R, Kale RK, Rao AR: Influence of certain essential oils on carcinogen-metabolizing enzymes and acidsoluble sulfhydryls in mouse liver. Nutr Cancer. 1994; 21: 263–269. Bayala B, Bassole IH, Gnoula C, Nebie R, Yonli A, Morel L, Figueredo G, Nikiema JB, Lobaccaro JM, Simpore J. Chemical composition, antioxidant, anti-inflammatory and anti-proliferative activities of essential oils of plants from burkina faso. PLoS One. 2014; 9: e92122. Bhatavdekar JM, Patel DD, Vora HH, Balar DB. Circulating markers and growth factors as prognosticators in men with advanced tongue cancer. Tumour Biol 1993;14:55–58. Bhatavdekar JM, Patel DD, Vora HH, Balar DB. Circulating prolactin and TPS in monitoring the clinical course of male patients with metastatic tongue cancer: a preliminary study. Anticancer Res 1993;13:237–40. Bhattacharjee S, Rana T, Sengupta A. Inhibition of lipid peroxidation and enhancement of GST activity by cardamom and cinnamon during chemically induced colon carcinogenesis in Swiss albino mice. Asian Pac J Cancer Prev. 2007; 8: 578-582. Boxem M. Cyclin-dependent kinase in C. elegans. Cell Div. 2006; 1: 6. Braakhuis BJ, Tabor MP, Leemans CR, van der Waal I, Snow GB, Brakenhoff RH. Second primary tumors and field cancerization in oral and oropharyngeal cancer: molecular techniques provide new insights and definitions. Head Neck 2002;24:198–206. Brandl A, Wagner T, Uhlig KM, Knauer SK, Stauber RH, Melchior F, Schneider G, Heinzel T, Kramer OH. Dynamically regulated sumoylation of HDAC2 controls p53 deacetylation and restricts apoptosis following genotoxic stress. J Mol Cell Biol. 2012; 4: 284-293. Brailo V, Vucicevic-Boras V, Cekic-Arambasin A, Alajbeg IZ, Milenovic A, Lukac J. The significance of salivary interleukin 6 and tumor necrosis factor alpha in patients with oral leukoplakia. Oral Oncol. 2006; 42: 370-377. Carew JS, Giles FJ, Nawrocki ST. Histone deacetylase inhibitors: mechanisms of cell death and promise in combination cancer therapy. Cancer Lett. 2008; 269: 7-17. Carnesecchi S, Schneider Y, Ceraline J, Duranton B, Gosse F, Seiler N, Raul F. Geraniol, a component of plant essential oils, inhibits growth and polyamine biosynthesis in human colon cancer cells. J Pharmacol Exp Ther. 2001; 298: 197-200. Chang KW, Chang CS, Lai KS, Chou MJ, Choo KB. High prevalence of human papillomavirus infection and possible association with betel quid chewing and smoking in oral epidermoid carcinomas in Taiwan. J Med Virol 1989; 28: 57–61. Chaudhary SC, Siddiqui MS, Athar M, Alam MS. Geraniol inhibits murine skin tumorigenesis by modulating COX-2 expression, Ras-ERK1/2 signaling pathway and apoptosis. J Appl Toxicol. 2013; 33: 828-837. Chen CJ, Lai CC, Tseng MC, Liu YC, Liu YH, Chiou LW, Tsai FJ. A novel titanium dioxide-polydimethylsiloxane plate for phosphopeptide enrichment and mass spectrometry analysis. Anal Chim Acta. 2014; 812:105-13. Chen J, Lu M, Jing Y, Dong J. The synthesis of L-carvone and limonene derivatives with increased antiproliferative effect and activation of ERK pathway in prostate cancer cells. Bioorg Med Chem. 2006; 14: 6539-6547. Chen J, Li L, Su J, Li B, Chen T, Wong YS. Synergistic apoptosis-inducing effects on A375 human melanoma cells of natural borneol and curcumin. PLoS One. 2014; 9:e101277. Chen WQ, Xu B, Mao JW, Wei FX, Li M, Liu T, Zhang LR. Inhibitory effects of α-pinene on hepatoma cell proliferation. Asian Pac J Cancer Prev. 2014; 15: 3293-3297. Daswani L, Bohra A: Toxic effect of Elettaria cardamomum (choti elaichi) on the growth of Salmonella typhi. Adv Plant Sci 2003; 16: 87–89. de RuiJter AJ, van Gennip AH, Caron HN, Kemp S, van Kuilenburg AB. Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem J. 2003; 370: 737-749. de Jong EP, Xie H, Onsongo G, Stone MD, Chen XB, Kooren JA, Refsland EW, Griffin RJ, Ondrey FG, Wu B, Le CT, Rhodus NL, Carlis JV, Griffin TJ. Quantitative proteomics Revels myosin, actin as promising saliva biomarkers for distinguishing pre-malignant, malignant oral lesions. PLoS One. 2010; 5: e11148. Delom F, Chevet E. Phosphoprotein analysis: from proteins to proteomes. Proteome Sci. 2006; 19; 4:15. Du XL, Hu H, Lin DC, et al. Proteomic profiling of proteins dysregulted in Chinese esophageal squamous cell carcinoma. J Mol Med 2007; 85: 863–75. Duncan RE, Lau D, El-Sohemy A, Archer MC. Geraniol and β-ionone inhibit proliferation, cell cycle progression, and cyclin-dependent kinase 2 activity in MCF-7 breast cancer cells independent of effects on HMG-CoA reductase activity. Biochem Pharmacol. 2004; 68: 1739-1749. Ehrnhofer-Ressler MM, Fricke K, Pignitter M, Walker JM, Walker J, Rychlik M, Somoza V. Identification of 1,8-Cineole, Borneol, Camphor, and Thujone as Anti-inflammatory Compounds in a Salvia officinalis L. Infusion Using Human Gingival Fibroblasts. J Agric Food Chem. 2013; 61: 3451-3459. Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol. 2007; 35: 495-516. El-Naggar AK, Mao L, Staerkel G, Coombes MM, Tucker SL, Luna MA, et al. Genetic heterogeneity in saliva from patients with oral squamous carcinomas: implications in molecular diagnosis and screening. J Mol Diagn 2001; 3: 164–70. Elgayyar M, Draughon FA, Golden DA, Mount JR: Antimicrobial activity of essential oils from plants against selected pathogenic and saprophytic microorganisms. J Food Prot 2001; 64:1019–1024. Emara M, Turner AR, Allalunis-Turner J. Adult, embryonic and fetal hemoglobin are expressed in human glioblastoma cells. Int J Oncol. 2014; 44: 514-520. Emiliani S, Fischle W, Van Lint C, Al-Abed Y, Verdin E. Characterization of a human RPD3 ortholog, HDAC3. Proc Natl Acad Sci U S A. 1998; 95: 2795-2800. Ernest NJ, Habela CW, Sontheimer H. Cytoplasmic condensation is both necessary and sufficient to induce apoptotic cell death. J Cell Sci 2008;121:290-297. Escaffit F, Vaute O, Chevillard-Briet M, Segui B, Takami Y, Nakayama T, Trouche D. Cleavage and cytoplasmic relocalization of histone deacetylase 3 are important forapoptosis progression. Mol Cell Biol. 2007; 27(2):554-67. Farag MA, Al-Mahdy DA. Comparative study of the chemical composition and biological activities of Magnolia grandiflora and Magnolia virginiana flower essential oils. Nat Prod Res. 2013; 27: 1091-1097. Favaloro B, Allocati N, Graziano V, Di Ilio C, De Laurenzi V. Role of apoptosis in disease. Aqing. 2012; 4: 330-339. Fischle W, Emiliani S, Hendzel MJ, Nagase T, Nomura N, Voelter W, Verdin E. A new family of human histone deacetylases related to Saccharomycescerevisiae HDA1p. J Biol Chem. 1999; 274: 11713-11720. Franzmann EJ, Reategui EP, Carraway KL, Hamilton KL, Weed DT, Goodwin WJ. Salivary soluble CD44: a potential molecular marker for head and neck cancer. Cancer Epidemiol Biomarkers Prev 2005;14:735–9. Franzmann EJ, Reategui EP, Pedroso F, Pernas FG, Karakullukcu BM, Carraway KL, et al. Soluble CD44 is a potential marker for the early detection of head and neck cancer. Cancer Epidemiol Biomarkers Prev 2007;16:1348–55. Fujita T, Ishikawa Y. Apoptosis in heart failure. The role of the β-adrenergic receptor-mediated signaling pathway and p53-mediated signaling pathway in the apoptosis of cardiomyocytes. Circ J. 2011; 75: 1811-1818. Galasinski SC, Resing KA, Goodrich JA, Ahn NG. Phosphatase inhibition leads to histone deacetylases 1 and 2 phosphorylation and disruption of corepressor interactions. J Biol Chem. 2002, 277:19618-19626. Gao L, Cueto MA, Asselbergs F, Atadja P. Cloning and functional characterization of HDAC11, a novel member of thehuman histone deacetylase family. J Biol Chem. 2002; 277: 25748-25755. Gilani AH, Jabeen Q, Khan AU, Shah AJ. Gut modulatory, blood pressure lowering, diuretic and sedative activaties of cardamom. J Ethnophamacol. 2008; 115:463-472. Grebhardt S, Müller-Decker K, Bestvater F, Hershfinkel M, Mayer D. Impact of S100A8/A9 expression on prostate cancer progression in vitro and in vivo. J Cell Physiol. 2013; 229: 661-671. Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM. editors. AJCC cancer staging manual. 7th ed. New York: Springer-Verlag. 2010. Grozinger CM, Hassig CA, Schreiber SL. Three proteins define a class of human histone deacetylases related to yeastHda1p. Proc Natl Acad Sci U S A. 1999; 96: 4868-4873. Gu Y, Ting Z, Qiu X, Zhang X, Gan X, Fang Y, Xu X, Xu R. Linalool preferentially induces robust apoptosis of a variey of leukemia cells via upregulating p53 and cyclin-dependent kinase inhibitors. Toxicology. 2010; 268: 19-24. Gu W, Roeder RG. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminaldomain. Cell. 1997; 90(4):595-606. Hatziieremia S, Gray AI, Ferro VA, Paul A, Plevin R. The effects of cardamonin on lipopolysaccharide-induced inflammatory protein production and MAP kinase and NFkappaB signaling pathways in monocytes/macrophages. Br J Pharmacol. 2006; 149: 188-198. Hacki J, Egger L, Monney L, Conus S, Rosse T, Fellay I, Borner C. Apoptosis crosstalk between the endoplasmic reticulum and mitochondria controlled by Bcl-2. Oncogene. 2000; 19: 2286-2295. Heizmann CW, Fritz G, Schäfer BW. S100 proteins: structure, functions and pathology. Front Biosci. 2002; 7: d1356-68. Hellner D, Klapdor R, Gundlach KH, Schmelze R. Results with the use of the Scc antigen in squamous cell carcinomas of the oral cavity. Dtsch Z Mund Kiefer Gesichtschir 1989;13:291–5. Herr I, Debatin KM. Cellular stress response and apoptosis in cancer therapy. Blood. 2001; 98: 2603-2614. Hillenkamp MKaF. Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons. Anal. Chem. 1988; 60: 2291-2301. Hirota R, Roger NN, Nakamura H, Song HS, Sawamura M, Suganuma N. Anti-inflammatory Effects of Limonene from Yuzu (Citrus junos Tanaka) Essential Oil on Eosinophils. J Food Sci. 2010; 75: H87-92. Hoffmann J, Munz A, Krimmel M, Alfter G. Intraoperative and postoperative kinetics of serum tumor markers in patients with oral carcinoma. J Oral Maxillofac Surg 1998;56:1390–3. Holm R, Knopp S, Kumar R, et al. Expression of ZNF652, a novel zinc finger protein, in vulvar carcinomas and its relation to prognosis. J Clin Pathol 2008; 61: 59–63. Horvitz HR. Genetic control of programmed cell death in the nematode Caenorhabditis elegans. Cancer Res. 1999; 59: 1701s–1706s. Hu S, Yu T, Xie Y, Yang Y, Li Y, Zhou X, Tsung S, Loo RR, Loo JR, Wong DT. Discovery of oral fluid biomarkers for human oral cancer by mass spectrometry. Cancer Genomics Proteomics. 2007; 4: 55-64. Hu S, Arellano M, Boontheung P, Wang J, Zhou H, Jiang J, Elashoff D, Wei R, Loo JA, Wong DT. Salivary proteomics for oral cancer biomarker discovery. Clin Cancer Res 2008; 14: 6246–6252. Hu S, Yu T, Xie Y, Yang Y, Li Y, Zhou X, Tsung S, Loo RR, Loo JR, Wong DT. Discovery of oral fluid biomarkers for human oral cancer by mass spectrometry.Cancer Genomics Proteomics. 2007; 4(2): 55-64. Hunter T. Protein kinases and phosphatases: the yin and yang of protein hosphorylation and signaling. Cell. 1995; 80(2):225-36. Jamal A, Javed K, Aslam M, Jafri MA. Gastroprotective effeft of cardamom, Elettaria cardamomum Maton. Fruits in rats. J Ethnophamacol. 2006; 103: 149-153. Johnstone RW, Licht JD. Histone deacetylase inhibitors in cancer therapy: is transcription the primary target? Cancer Cell 2003; 4: 13–18. Jou YJ, Lin CD, Lai CH, Chen CH, Kao JY, Chen SY, Tsai MH, Huang SH, Lin CW. Proteomic identification of salivary transferrin as a biomarker for early detection of oral cancer. Anal Chim Acta. 2010; 681: 41–48. Joza N, Susin SA, Daugas E, Stanford WL, Cho SK, Li CY, Sasaki T, Elia AJ, Cheng HY, Ravagnan L, Ferri KF, Zamzami N, Wakeham A, Hakem R, Yoshida H, Kong YY, Mak TW, Zúñiga-Pflücker JC, Kroemer G, Penninger JM. Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death. Nature 2001;410:549-554. Juan LJ, Shia WJ, Chen MH, Yang WM., Seto E, LinYS, Wu CW. Histone deacetylases specifically down-regulate p53-dependent gene activation. J Biol Chem. 2000, 275:20436-20443. Jung KH, Noh JH, Kim JK, Eun JW, Bae HJ, Xie HJ, Chang YG, Kim MG, Park H, Lee JY, Nam SW. HDAC2 overexpression confers oncogenic potential to human lung cancer cells by deregulating expression of apoptosis and cell cycle proteins. J Cell Biochem. 2012; 113: 2167-2177. Kaplia AA, Khizhniak SV, Kudriavtseva AG, Papageorgakopulu N, Osinkii DS. Na+, K+-ATPase and Ca+-ATPase isozymes in malignant neoplasms. Ukr Biokhim Zh. 2006; 78: 29-42. Kaur J, Matta A, Kak I, Srivastava G, Ass J, Leong I, Witterick I, Colgan TJ, Macmillan C, Siu KW, Walfish PG, Ralhan R. S100A7 overexpression is a predictive marker for high risk of malignant transformation in oral dysplasia. Int J Cancer. 2013; 134: 1379-1388. Kelland L. The resurgence of platinum-based cancer chemotherapy. Nat Rev Cancer. 2007, 7(8):573-84. Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972;26:239–57. Kerr JF. History of the events leading to the formulation of the apoptosis concept. Toxicology. 2002;181–182:471–4. Khabele D. The therapeutic potential of class I selective histone deacetylase inhibitors in ovarian cancer. Front Oncol. 2014, 4:111. Khan NA, Rahman SZ. The screening of Majoon-e-Azaraqi for cartliovascular and peripheral activity. Hamdard Med. 1995; 35: 102-109. Kim HJ, Kang HJ, Lee H, Lee ST, Yu MH, Lim H, Lee C. Identification of S100A8 and S100A9 as serological markers for colorectal cancer. J Proteome Res. 2008; 8: 1368–1379. Kim HK, Wilson EG, Choi YH, Verpoorte R. Metabolomics: a tool for anticancer lead-finding from natural products. Planta Med. 2010, 76(11):1094-102. Kinghorn AD, Pan L, Fletcher JN, Chai H. The relevance of higher plants in lead compound discovery programs. J Nat Prod. 2011, 74(6):1539-55. Klionsky DJ, Emr SD. Autophagy as a regulated pathway of cellular degradation. Science 2000;290:1717-1721. Knights CD, Catania J, Di Giovanni S, Muratoglu S, Perez R, Swartzbeck A, Quong AA, Zhang X, Beerman T,Pestell RG, Avantaggiati ML. Distinct p53 acetylation cassettes differentially influence gene-expression patternsand cell fate. J Cell Biol. 2006; 173(4):533-44. Ko YC, Huang YL, Lee CH, Chen MJ, Lin LM, Tsai CC. Betel quid chewing, cigarette smoking and alcohol consumption related to oral cancer in Taiwan. J Oral Pathol Med 1995; 24: 450–3. Komiya T, Kyohkon M, Ohwaki S, Eto J, Katsuzaki H, Imai K, Kataoka T, Yoshioka K, Ishii Y, Hibasami H. Phtol induces programmed cell death in human lymphoid leukemia Molt 4B cells. Int J Mol Med. 1999; 4: 377-380. Kovacs JJ, Murphy PJ, Gaillard S, Zhao X, Wu JT, Nicchitta CV, Yoshida M, Toft DO, Pratt WB, Yao TP. HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation ofglucocorticoid receptor. Mol Cell. 2005; 18:601-607. Krimmel M, Hoffmann J, Krimmel C, Cornelius CP, Schwenzer N. Relevance of SCC-Ag, CEA, CA 19.9 and CA 125 for diagnosis and follow-up in oral cancer. J Craniomaxillofac Surg 1998;26:243–8. Kroemer G., Reed JC. Mitochondrial control of cell death. Nat Med 2000;6:513-519. Kumar R, Manning J, Spendlove HE, et al. ZNF652, a novel zinc finger protein, interacts with the putative breast tumor suppressor CBFA2T3 to repress transcription. Mol Cancer Res 2006;4:655–65. Kurokawa H, Tsuru S, Okada M, Nakamura T, Kajiyama M. Evaluation of tumor markers in patients with squamous cell carcinoma in the oral cavity. Int J Oral Maxillofac Surg 1993;22:35–8. Kurokawa H, Yamashita Y, Tokudome S, Kajiyama M. Combination assay for tumor markers in oral squamous cell carcinoma. J Oral Maxillofac Surg 1997;55:964–6. Kwan HW. A statistical study on oral carcinomas in Taiwan with emphasis on the relationship with betel nut chewing: a preliminary report. J Formosan Med Assoc 1976; 75: 497–505. Ladomery M, Dellaire G. Multifunctional zinc finger proteins in development and disease. Ann Hum Genet 2002;66:331–42. Lander ES. et al. Initial sequencing and analysis of the human genome. Nature. 2001; 409: 860-921. Lane AA, Chabner BA. Histone deacetylase inhibitors in cancer therapy. J Clin Oncol. 2009; 27: 5459-5468. Lee JH, Takahashi T, Yasuhara N, Inazawa J, Kamada S, Tsujimoto Y., Bis, a Bcl-2-binding protein that synergizes with Bcl-2 in preventing cell death. Oncogene. 1999; 18: 6183-6190. Lei WW, Zhang KH, Pan XC, Wang DM, Hu Y, Yang YN, Song JG. Histone deacetylase 1 and 2 differentially regulate apoptosis by opposing effectson extracellular signal-regulated kinase 1/2. Cell Death Dis. 2010; 1:e44. Lemoine M, Younes A. Histone deacetylase inhibitors in the treatment of lymphoma. Discov Med. 2010; 10:462-470. Li Y,Wen T, ZhuM, Li L, Wei J, Wu X, Guo M, Liu S, Zhao H, Xia S, Huang W, Wang P, Wu Z, Zhao L, Shui W, Li Z, Yin Z. Glycoproteomic analysis of tissues frompatients with colon cancer using lectin microarrays and nanoLC–MS/MS. Mol Biosyst. 2013; 9: 1877–1887. Li Y, Elashoff D, Oh M, Sinha U, St John MA, Zhou X, Abemayor E, Wong DT. Serum circulating human mRNA profiling and its utility for oral cancer detection. J Clin Oncol. 2006; 24: 1754-1760. Lin CC, Yang JS, Chen JT, Fan S, Yu FS, Yang JL, Lu CC, Kao MC, Huang AC, Lu HF, Chung JG. Berberine induces apoptosis in human HSC-3 oral cancer cells viasimultaneous activation of the death receptor-mediated and mitochondrialpathway. Anticancer Res. 2007; 27: 3371-3378. Lingen MW, Polverini PJ, Bouck NP. Retinoic acid induces cells cultured from oral squamous cell carcinomas tobecome anti-angiogenic. Am J Pathol. 1996; 149: 247-258. Lippman SM, Hong WK. Molecular markers of the risk of oral cancer. NEngl JMed 2001;344:1323-6. And Vokes EE,WeichselbaumRR, Lippman SM, et al.Head and neck cancer. NEngl JMed 1993;328:184-94. Liu CJ, Lin SC, Yang CC, Cheng HW, Chang KW. Exploiting salivary miR-31 as a clinical biomarker of oral squamous cell carcinoma. Head Neck. 2012 Feb;34(2):219-24. Liu H,Wang L,Wang X, Cao Z, Yang Q, Zhang K. S100A7 enhances invasion of human breast cancer MDA-MB-468 cells through activation of nuclear factor-κB signaling. World J Surg Oncol. 2013; 11: 93. Lu CT, Yen YY, Ho CS, et al. A case-control study of oral cancer in Changhua County, Taiwan. J Oral Pathol Med 1996; 25: 245–8. Lidwig H, Sundal E, Pecherstorfer M, Leitgeb C, Bauernhofer T, Beinhauer A, Samonigg H, Kappeler AW, Fritz E. Recombinant human erythropoietin for the correction of cancer associated anemia with and without concomitant cytotoxic chemotherapy. Cancer. 1995; 76: 2319-2329. Ma P, Pan H, Montgomery RL, Olson EN, Schultz RM. Compensatory functions of histone deacetylase 1 (HDAC1) and HDAC2 regulatetranscription and apoptosis during mouse oocyte development. Proc Natl Acad Sci U S A. 2012; 109(8):E481-9. Mackay JP, Crossley M. Zinc fingers are sticking together. Trends Biochem Sci 1998;23:1–4. Mancini F, Moretti F. Mitochondrial MDM4 (MDMX): an unpredicted role in the p53-mediated intrinsic apoptotic pathway. Cell Cycle. 2009; 8: 3854-3859. Mahady GB, Pendland SL, Stoia A, et al.: In vitro susceptibility of Helicobacter pylori to botanical extracts used traditionally for the treatment of gastrointestinal disorders. Phytother Res 2005; 19: 988–991. Marks P, Rifkind RA, Richon VM, Breslow R, Miller T, Kelly WK. Histone deacetylases and cancer: causes and therapies. Nat Rev Cancer. 2001; 1: 194-202. Matsuo AL, Flgueiredo CR, Arruda DC, Pereira FV, Scutti JA, Massaoka MH, Travassos LR, Sartorelli P, Lago JH. α-pinene isolated from Schinus terebinthifolius Raddi (Anacardiaceae) induces apoprtosis and confers antimetastatic protection in a melanoma model. Biochem Biophys Res Commun. 2011; 411: 449-454. Martin TS, Kikuzaki H, Hisamoto M, Nakatani N. Constituents of Amomum tsao-ko and their radical scavenging and antioxidant activities. J Am Oil Chem. 2000; 77: 667-673. McComb ME, Perlman DH, Huang H, Costello CE. Evaluation of an on-target sample preparation system for matrix-assisted laser desorption/ionization time-of-flight mass spectrometry in conjunction with normal-flow peptide high-performance liquid chromatography for peptide mass fingerprint analyses. Rapid Commun Mass Spectrom. 2007; 21: 44-58. Medzihradszky KF, Campbell JM, Baldwin MA, Falick AM, Juhasz P, Vestal ML, Burlingame AL. The characteristics of peptide collision-induced dissociation using a high-performance MALDI-TOF/TOF tandem mass spectrometer. Anal. Chem. 2000; 72: 552-558. Mi H, Muruganujan A, Casagrande JT, Thomas PD. Large-scale gene function analysis with the PANTHER classification system. Nat Protoc. 2013; 8: 1551-1566. Miller JA, Thompson PA, Hakim IA, Lopez AM, Thomson CA, Chew W, Hsu CH, Chow HH. Safety and Feasibility of Topical Application of Limonene as a Massage Oil to the Breast. J Cancer Ther. 2012; PMCID:PMC3824622. Mo W, Karger BL. Analytical aspects of mass spectrometry and proteomics. Curr. Opin. Chem. Biol. 2002; 6:666-675. Mosca E, Alfieri R, Merelli I, Viti F, Calabria A, Milanesi L. A multilevel data integration resource for breast cancer study. BMC Syst Biol 2010; 4: 76. Moteki H, Hibasami H, Yamada Y, Katsuzaki H, Imai L, Komiya T. Specific induction of apoptosis by 1, 8-cineole in two human leukemia vell lines, but not a in human stomach cancer cell line. Oncol Reg. 2002; 9: 757-760. Moon SS, Lee JY, Cho SC. Isotsaokoin, an antifungal agent from Amomum tsao-ko. J Nat Prod. 2004; 67: 889-891. Moon SS, Cho SC, Lee JY. Tsaokoarylone, a cytotoxic diarylheptanoid from Amomum tsao-ko fruits. B Kor Chem. 2005; 26: 447-450. Morishima N, Nakanishi K, Takenouchi H, Shibata T, Yasuhiko Y. An endoplasmic reticulum stress-sapecific caspase cascade in apoptosis. Cytochrome c-independent activation of caspase-9 by caspase-12. J Biol Chem. 2002; 277: 34287-34294. Murata S, Shiragami R, Kosugi C, Tezuka T, Yamazaki M, Hirano A, Yoshimura Y, Suzuki M, Shuto K, Ohkohchi N, Koda K. Antitumor effect of 1, 8-cineole against colon cancer. Oncol Rep. 2013; 30: 2647-2657. Nagler R, Bahar G, Shpitzer T, Feinmesser R. Concomitant analysis of salivary tumor markers – a new diagnostic tool for oral cancer. Clin Cancer Res 2006;12:3979–84. Nagler RM, Barak M, Ben-Aryeh H, Peled M, Filatov M, Laufer D. Early diagnostic and treatment monitoring role of Cyfra 21-1 and TPS in oral squamous cell carcinoma. Cancer 1999;35:1018–25. Nagler RM, Braun J, Daitzman M, Laufer D. Spiral CT angiography – an alternative vascular evaluation technique for head and neck microvascular reconstruction: a preliminary experience. Plast Reconst Surg 1997;100:1697–703. Nagler RM. Saliva as a tool for oral cancer diagnosis and prognosis. Oral Oncol. 2009 Dec;45(12):1006-1010. Nagoor NH, Shah Jehan Muttiah N, Lim CS, In LL, Mohamad K, Awang K. Regulation of apoptotic effects by erythrocarpine E, a cytotoxic limonoidfrom Chisocheton erythrocarpus in HSC-4 human oral cancer cells. PLoS One. 2011; 6: e23661. Naqappan A, Park HS, Park KI, Kim JA, Hong GE, Kang SR, Zhang J, Kim EH, Lee WS, Won CK, Kim GS. Proteomic analysis of differentiallyexpressed proteins in Vitamin C-treated AGS cells. BMC Biochem. 2013; 14: 24. Norbury CJ, Hickson ID. Cellular responses to DNA damage. Annu Rev Pharmacol Toxicol. 2001;41:367–401. [PubMed: 11264462] Ohnishi Y, Minamino Y, Kakudo K, Nozaki M. Resistance of oral squamous cell carcinoma cells to cetuximab is associated with EGFR insensitivity and enhanced stem cell-like potency. Oncol Rep. 2014; 32: 780-786. O'Neill VJ, Twelves CJ. Oral cancer treatment: developments in chemotherapy and beyond. Br J Cancer. 2002; 87: 933-937. Opstal-vanWinden AW, Krop EJ, Kåredal MH, Gast MC, Lindh CH, Jeppsson MC, Jonsson BA, Grobbee DE, Peeters PH, Beijnen JH, van Gils CH, Vermeulen RC. Searching for early breast cancer biomarkers by serum protein profiling of pre-diagnostic serum; a nested case–control study. BMC Cancer. 2011; 11:381. Ouaïssi M, Sielezneff I, Silvestre R, Sastre B, Bernard JP, Lafontaine JS, Payan MJ, Dagan L, Pirro N, Seitz JF, Mas E, Lombardo D, Ouaissi A. High histone deacetylase 7 (HDAC7) expression is significantly associated with adenocarcinomas of the pancreas. Ann Surg Oncol. 2008; 15: 2318-2328. Ozaki T, Wu D, Sugimoto H, Nagase H, Nakagawara A. Runt-related transcription factor 2 (RUNX2) inhibits p53-dependent apoptosisthrough the collaboration with HDAC6 in response to DNA damage. Cell Death Dis. 2013; 4:e610. Park SJ, Kim MJ, Kim YK, Kim SM, Park JY, Myoung H. Combined cetuximab and genistein treatment shows additive anti-cancereffect on oral squamous cell carcinoma. Cancer Lett. 2010; 292: 54-63. Parris TZ, Kovács A, Aziz L, Hajizadeh S, Nemes S, Semaan M, Forssell-Aronsson E, Karisson P, Helou K. Additive effect of the AZGP1, PIP, S100A8, and UBE2C molecular biomarkers improves outcome prediction in breast carcinoma. Int J Cancer. 2013; 134: 1617-1629. Paweletz N. Walther Flemming: pioneer of mitosis research. Nat Rev Mol Cell Biol. 2001;2:72–5. [PubMed: 11413469] Peart MJ, Tainton KM, Ruefli AA, Dear AE, Sedelies KA, O'Reilly LA, Waterhouse NJ, Trapani JA, Johnstone RW. Novel mechanisms of apoptosis induced by histone deacetylase inhibitors. Cancer Res. 2003; 63:4460-4471. Peana AT, D'Aquila PS, Panin F, Serra G, Pippia P, Moretti MD. Anti-inflammatory activity of linalool and linalyl acetate constituents of essential oils. Phytomedicine. 2002; 9: 721-726. Pluemsampant S, Safronova OS, Nakahama K, Morita I. Protein kinase CK2 is a key activator of histone deacetylase in hypoxia-associated tumors. Int J Cancer. 2008, 122:333-341. Polizzi D, Pratesi G, Monestiroli S, Tortoreto M, Zunino F, Bombardelli E, Riva A, Morazzoni P, Colombo T, D'lncalci M, Zucchetti M. Oral efficacy and bioavailability of a novel taxane. Clin Cancer Res. 2000; 6: 2070-2074. Prince HM, Bishton MJ, Harrison SJ. Clinical studies of histone deacetylase inhibitors. Clin Cancer Res. 2009; 15: 3958-3969. Qiblawi S, Al-Hazimi A, Al-Mogbel M, Hossain A, Bagchi D. Chemopreventive Effects of Cardamom (Elettaria cardamomum L.) on Chemically Induced Skin Carcinogenesis in Swiss Albino Mice. J Med Food. 2012; 15: 576–580. Qiu S, Shou D, Chen L, Dai H, Liu K. Pharmacological comparison between volatile oil and water extract. Zhongguo Zhong Yao Za Zhi. 1999; 24: 297-299. Reichart P, Mohr U. Correlation between chewing and smoking habits and precancerous lesions in hill tribes of northern Thailand. IARC. Lyon: Scientific Publications, 1987; 463–4. Rhodus NL, Ho V, Miller CS, Myers S, Ondrey F. NF-kappaB dependent cytokine levels in saliva of patients with oral preneoplastic lesions and oral squamous cell carcinoma. Cancer Detect Prev. 2005; 29: 42-45. Riedl S J, Salvesen GS. The apoptosome: signalling platform of cell death. Nat Rev Mol Cell Biol. 2007, 8:405-413. Righini CA, de Fraipont F, Reyt E, Favrot MC. Aberrant methylation of tumor suppressor genes in head and neck squamous cell carcinoma: is it clinically relevant? Bull Cancer 2007;94:191–197. Righini CA, de Fraipont F, Timsit JF, Faure C, Brambilla E, Reyt E, et al. Tumorspecific methylation in saliva: a promising biomarker for early detection of head and neck cancer recurrence. Clin Cancer Res 2007;13:1179–1185. Rodriquez-Gonzalez A, Lin T, Ikeda AK, Simma-Waldrip T, Fu C, Sakamoto KM. Role of the aggresome pathway in cancer: targeting histone deacetylase 6-dependent protein degradation. Cancer Res. 2008; 68: 2557-2560. Rosas SL, Koch W, da Costa Carvalho MG, Wu L, Califano J, Westra W, et al. Promoter hypermethylation patterns of p16, O6-methylguanine-DNAmethyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients. Cancer Res 2001;61:939–42. Rush J, Moritz A, Lee KA, Guo A, Goss VL, Spek EJ, Zhang H, Zha XM, Polakiewicz RD, Comb MJ. Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. Nat Biotechnol. 2005, 23:94-101. Sakuma T, Uzawa K, Onda T, Shiiba M, Yokoe H, Shibahara T, Tanzawa H. Aberrant expression of histone deacetylase 6 in oral squamous cell carcinoma. Int J Oncol. 2006; 29: 117-124. Sakurai T, Itoh K, Higashitsuji H, Nagao T, Nonoguchi K, Chiba T, Fujita J. A cleaved form of MAGE-A4 binds to Miz-1 and induces apoptosis in human cells. Chem. 2004; 279: 15505-15514. Samuel CE. ADARs: viruses and innate immunity. Curr Top Microbiol Immunol. 2012; 353: 163-195. Sanghvi LD. Cancer epidemiology: the Indian scene. J Cancer Res Clin Oncol 1981; 99: 1–14. Santos FA, Rao VS. Antiinflammatory and antinociceptive effects of 1,8-cineole a terpenoid oxide present in many plant essential oils. Phytother Res. 2000; 14: 240-244. Schaaij-Visser TB, de Wit M, Lam SW, Jiménez CR. The cancer secretome, current status and opportunities in the lung, breast and colorectal cancer context. Biochim Biophys Acta. 2013; 1834: 2242–2258. Scorrano L, Ashiya M, Buttle K, Weiler S, Oakes SA, Mannella CA, Korsmeyer SJ. A distinct pathway remodels mitochondrial cristae and mobilizes cytochrome c during apoptosis. Dev Cell 2002; 2: 55-67. Sekine T, Sugano M, Majid A, Fujii Y: Antifungal effects of volatile compounds from black zira (Bunium persicum) and other spices and herbs. J Chem Ecol 2007; 33: 2123–2132. Sengupta A, Ghosh S, Bhattacharjee S: Dietary cardamom inhibits the formation of azoxymethane-induced aberrant crypt foci in mice and reduces COX-2 and iNOS expression in the colon. Asian Pac J Cancer Prev 2005; 6: 118–122. Shah FD, Begum R, Vajaria BN, Patel KR, Patel JB, Shukla SN, Patel PS. A review on salivary genomics and proteomics biomarkers in oral cancer. Indian J Clin Biochem. 2011 Oct;26(4):326-34. Shareef H, Rizwani GH, Mandukhail SR, Waranabe N, Gilani AH. Studies on antidiarrhoeal, antispasmodic and bronchodilator activities of Operculina turpethum Linn. BMC Complement Altern Med. 2014; 14: 479. Shpitzer T, Bahar G, Feinmesser R, Nagler RM. A comprehensive salivary analysis for oral cancer diagnosis. Cancer Res Clin Oncol 2007;133:613–7. Shpitzer T, Hamzany Y, Bahar G, et al. Salivary analysis of oral cancer biomarkers. Br J Cancer 2009;101:1194–1198. Sinha D, Bannergee S, Schwartz JH, Lieberthal W, Levine JS. Inhibition of ligand-independent ERK1/2 activity in kidney proximal tubular cells deprived of soluble survival factors up-regulates Akt and prevents apoptosis. J Biol Chem. 2004; 279: 10962-10972. Skaggs HS, Saunders BA, Miller RW, Goodrich ST, King MS, Kimbler KD, Branscum AJ, Fung ET, DePries PD, van Nagell JR, Ueland FR, Baron AT. Ovarian cyst fluids are a cache of tumor biomarkers that include calgranulin A and calgranulin B isoforms. Cancer Invest. 2013; 31: 433–453. Sobin LH, Mary K. TNM classification of malignant tumors. New York; Wiley; 2011. Sukumaran K, Kuttan R: Inhibition of tobacco-induced mutagenesis by eugenol and plant extracts. Mutat Res 1995; 343: 25–30. Su J, Lai H, Chen J, Li L, Wong YS, Chen T, Li X. Natural bornel, a monoterpenoid compound, potentiates selenocystine-induced apoptosis in human hepatocellular carcinoma cells by enhancement of celluar uptake and activation of ROS-mediated DNA damage. PLoS One. 2013; 20: e63502. Sun G, Yu RT, Evans RM, Shi Y. Orphan nuclear receptor TLX recruits histone deacetylases to repress transcription and regulate neural stem cell proliferation. Proc Natl Acad Sci U S A. 2007, 104:15282-15287. Sylvestre M, Pichette A, Longtin A, Nagau F, Legault J. Essential oil analysis and anticancer activity of leaf essential oil of Croton flavens L. from Guadeloupe. J Ethnopharmacol. 2006; 103: 99-102. Szabadkai G, Rizzuto R. Participation of endoplasmic reticulum and mitochondrial calcium handling in apoptosis: more than just neighborhood? FEBS Lett. 2004; 567: 111-115. Tanaka K. et al. Rapid Commun. Mass Spectrom. 1988; 2:151. Tang Y, Zhao W, Chen Y, Zhao Y, Gu W. Acetylation is indispensable for p53 activation. Cell. 2008, 133:612-626. Tanaka H, Arakawa H, Yamaguchi T, Shiraishi K, Fukuda S, Matsui K, Takei Y, Nakamura Y. A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage. Nature. 2000; 404: 42-49. Taunton J, Hassig CA, Schreiber SL. A mammalian histone deacetylase related to the yeast transcriptionalregulator Rpd3p. Science. 1996; 272: 408-411. Thomas SJ, MacLennan R. Slaked lime and betel nut cancer in Papua New Guinea. Lancet 1992; 340: 577–8. Tian X, Sun D, Zhang Y, Zhao S, Xiong H, Fang J. Zinc finger protein 278, a potential oncogene in human colorectal cancer. Acta Biochim Biophys Sin (Shanghai) 2008; 40: 289–96. Turhani D, Krapfenbauer K, Thurnher D, Langen H, Fountoulakis M. Identification of differentially expressed, tumor-associated proteins in oral squamous cell carcinoma by proteomic analysis. Electrophoresis. 2006; 27:1417-23. Van Geelen CM, de Vries EG, de Jong S. Lessons from TRAIL-resistance mechanisms in colorectal cancer cells: paving the road to patient-tailored therapy. Drug Resist Updat. 2004; 7: 345-358. Verdin E, Dequiedt F, Kasler HG. Class II histone deacetylase: versatile regulators. Trends Genet. 2003; 19: 286-293. Viet CT, Jordan RC, Schmidt BL. DNA promoter hypermethylation in saliva for the early diagnosis of oral cancer. J Calif Dent Assoc. 2007; 35: 844–849. Viet CT, Schmidt BL. Methylation array analysis of preoperative and postoperative saliva DNA in oral cancer patients. Cancer Epidemiol Biomarkers Prev. 2008; 17: 3603-3611. von Pawel J, Gatzemeier U, Puiol JL, Moreau L, Bildat S, Ranson M, Richardson G, Steppert C, Riviere A, Camlett I, Lane S, Ross G. Phase  comparator study of oral versus intravenous topotecan in patients with chemosensitive small-cell lung cancer. J Clin Oncol. 2001; 19: 1743-1749. Wagner T, Brand P, Heinzel T, Krämer OH. Histone deacetylase 2 controls p53 and is a critical factor in tumorigenesis. Biochim Biophys Acta. 2014; 1846: 524-438. Wang J, Yin H, Panandikar A, Gandhi V, Sen S. Elevated cyclin A associated kinase activity promotes sensitivity of metastatic human cancer cells to DNA antimetabolite drug. Int J Oncol. 2015; doi: 10.3892/ijo.2015.3037. Wang L, Chang EW, Wong SC, Ong SM, Chong DQ, Ling KL. Increased myeloid-derived suppressor cells in gastric cancer correlate with cancer stage and plasma S100A8/A9 proinflammatory proteins. J Immunol. 2013; 190: 794–804. Wasinger VC, Cordwell SJ, Cerpa-Poljak A, Yan JX, Gooley AA, Wilkins MR, Duncan MW, Harris R, Williams KL, Humphery-Smith I. Progress with gene-product mapping of the Mollicutes: Mycoplasma genitalium. Electrophoresis 1995, 16, 1090–1094. Warnakulasuriya S, Soussi T, Maher R, Johnson N, Tavassoli M. Expression of p53 in oral squamous cell carcinoma is associated with the presence of IgG and IgA p53 autoantibodies in sera and saliva of the patients. J Pathol. 2000; 192: 52-57. Weinberg RA. The retinoblastoma protein and cell cycle control. Cell. 1995; 81: 323-330. Wilkins MR, Sanchez JC, Gooley AA, Appel RD, Humphery-Smith I, Hochstrasser DF, Williams KL.Progress with proteome projects: why all proteins expressed by a genome should be identified and how to do it. Biotechnol. Genet. Eng. Rev. 1995, 13, 19–50. Wu X, Li X, Xiao F, Zhang Z, Xu Z, Wang H. Studies on the analgesic and anti-inflammatory effect of bornyl acerate in volatile oil from Amomum villosum. Zhong Yao Cai. 2004; 27: 438-439. Xu Y. Regulation of p53 responses by post-translational modifications. Cell Death Differ. 2003; 10:400-403. Yadav VR, Prasad S, Aggarwal BB. Cardamonin sensitizes tumor cells to TRAIL through ROS- and CHOP- mediated up-regulation of death receptors and down-regulation of survival proteins. Br J Pharmacol. 2012; 165: 741-753. Yajima I, Kumasaka M, Thang ND, et al. Zinc finger protein 28 as a novel melanoma-related molecule. J Dermatol Sci 2009;55:68–70. Yang WM, Inouye C, Zeng Y, Bearss D, Seto E. Transcriptional repression by YY1 is mediated by interaction with amammalian homolog of the yeast global regulator RPD3. Proc Natl Acad Sci U S A. 1996; 93: 12845-12850. Yang Y, Yue Y, Runwei Y, Guolin Z. Cytotoxic, apoptosis and antioxidant activity of the essential oil of Amomum tsao-ko. Bioresour Technol. 2010; 101: 4205-4211. Yang YY, Koh LW, Tsai JH, Tsai CH, Wong EF, Lin SJ, Yang CC. Involvement of viral and chemical factors with oral cance in Taiwan. Jpn J Clin Oncol. 2004, 34(4):176-83. Yang XZ, Kuenzi P, Plitzko I, Potterat O, Hamburger M. Bicyclononane aldegydes and antiproliferative constituents from Amomum tsao-ko. Planta Med. 2009; 75: 543-546. Ye L, Sun PH, Martin TA, Sanders AJ, Mason MD, Jiang WG. Psoriasin (S100A7) is a positive regulator of survival and invasion of prostate cancer cells. Urol Oncol. 2013; 31: 1576–1583. Yen CY, Chen CH, Chang CH, Tseng HF, Liu SY, Chuang LY, Wen CH, Chang HW. Matrix metalloproteinases (MMP) 1 and MMP10 but not MMP12 are potential oral cancer markers. Biomarkers. 2009; 14: 244–249. Yen CY, Huang CY, HouMF, Yang YH, Chang CH, Huang HW, Chen CH, Chang HW. Evaluating the performance of fibronectin 1 (FN1), integrin α4β1 (ITGA4), syndecan-2 (SDC2), and glycoprotein CD44 as the potential biomarkers of oral squamous cell carcinoma (OSCC). Biomarkers. 2013; 18: 63–72. Yen CY, Chiu CC, Haung RW, Yeh CC, Huang KJ, Chang KF, Hseu YC, Chang FR, Chang HW, Wu YC. Antiproliferative effects of goniothalamin on Ca9-22 oral cancer cellsthrough apoptosis, DNA damage and ROS induction. Mutat Res. 2012; 747: 253-258. Yen TC, Lin WY, Kao CH, Cheng KY, Wang SJ. A study of a new tumour marker, CYFRA 21-1, in squamous cell carcinoma of the head and neck, and comparison with squamous cell carcinoma antigen. Clin Otolaryngol 1998; 23: 82–86. Yogalakshmi B, Viswanathan P, Anuradha CV. Investigation of antioxidant, anti-inflammatory and DNA-protective properties of eugenol in thioacetamide-induced liver injury in rats. Toxicology. 2010; 268: 204-212. Zeng Y, Hu D, Din P, Chen J, Xu H. Study on quality standard of Fructus Amomi. Zhongguo Zhong Yao Za Zhi. 1999; 24: 651-653. Zhang H, Yan W, Aebersold R. Chemical probes and tandem mass spectrometry: a strategy for the quantitative analysis of proteomes and subproteomes. Curr Opin Chem Biol. 2004,8(1), 66-75. Zhang X, Leung SM, Morris CR, Shigenaga MK. Evaluation of a novel, integrated approach using functionalized magneticbeads, bench-top MALDI-TOF-MS with prestructured sample supports, andpattern recognition software for profiling potential biomarkers in humanplasma. J Biomol Tech. 2004; 15: 167-175. Zhang D, Li S, Xiong Q, Jiang C, Lai X. Extraction, characterization and biological activities of polysaccharides from Amomum Villosum. Carbohydr Polym. 2013; 95: 114-122. Zhang Z, Li M, Zhang G, Fang P, Yao H, Xiao Z, Chen Z.Identification of human gastric cacinoma biomarkers by differential protein expression analysis using 18O labeling and nanoLC–MS/MS coupled with laser capture microdissection. Med Oncol. 2010; 27: 296–303. Zhao Y, Lu S, Wu L, Chai G, Wang H, Chen Y, Sun J, Yu Y, Zhou W, Zheng Q, Wu M, Otterson GA, Zhu WG. Acetylation of p53 at lysine 373/382 by the histone deacetylase inhibitor depsipeptideinduces expression of p21(Waf1/Cip1). Mol Cell Biol. 2006; 26(7):2782-90. Zhao Y, Tan J, Zhuang L, Jiang X, Liu ET, Yu Q. Inhibitors of histone deacetylases target the Rb-E2F1 pathway for apoptosisinduction through activation of proapoptotic protein Bim. Proc Natl Acad Sci U S A. 2005; 102:16090-16095. Zhao M, Rosenbaum E, Carvalho AL, Koch W, Jiang W, Sidransky D, Califano J. Feasibility of quantitative PCR-based saliva rinse screening of HPV for head and neck cancer. Int J Cancer. 2005; 117: 605-610. Zhu W, Smith JW, Huang CM. Mass spectrometry-based label-free quantitative proteomics. J Biomed Biotechnol. 2010; 2010: 840518. Zhuang S, Schnellmann RG. A death-promoting role for extracellular signal-regulated kinase. J Pharmacol Exp Ther. 2006; 319: 991-997. Zhong LP, Chen GF, Xu ZF, Zhang X, Ping FY, Zhao SF. Detection of telomerase activity in saliva from oral squamous cell carcinoma patients. Int Oral Maxillofac Surg. 2005; 34: 566-570. Zoller J, Fiehn W, Mende U, Hotz G. The diagnostic value of the tumor markers CEA, 'Ca 19-9', 'Ca 125', 'Ca15-3' and 'SCC' for the detection of recurrent tumors in patients with tumors of the head and neck. Dtsch Z Mund Kiefer Gesichtschir 1990;14:254–9. Zoller J. The value of 'tumor markers' in the therapy and aftercare of carcinoma of the oral mucosa. Dtsch Zahn Mund Kieferheilkd Zentralbl 1992;80:351–7. Zou H, Li Y, Liu X, Wang X. An APAF-1. cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J Biol Chem. 1999;274:11549-1155
摘要: 
在全球,口腔癌(Oral squamous cell carcinoma, OSCC)的死亡率有逐漸上升的趨勢,另外在台灣,也是公共衛生問題之一。本篇研究目的在於使用基質輔助雷射脫附游離飛行時間質譜以及奈流液相層析質譜技術,利用非侵入性方法提取口腔癌患者唾液探討人類口腔癌唾液中蛋白以及胜肽的生物標誌,以及研發抗口腔癌藥物,瞭解其抗癌分子機制。
本研究於民國97年到101年間,收集到正常組27人以及口腔癌患者實驗組106人的唾液。利用C-8微粒磁珠以及基直輔助雷射脫附游離飛行時間質譜,找出唾液中的胜肽,接著利用ClinProTools軟體分析,找出有差異之胜肽質量2918.57 Da。進一步MS/MS鑑定此胜肽片段,得到ZNF510的胜肽。經由酵素免疫聯結吸附分析以及免疫組織染色發現,ZNF510在唾液中的ㄎ實驗組的表現比正常組高。根據areas sections receiver operating characteristic (AUROC)曲線,T1+T2所占面積比為0.95,因此得知ZNF510可以檢測早期的口腔癌。另外利用奈流液相層析質譜分析,人類口腔癌唾液之小分子(10 kDa~15 kDa)蛋白標誌,得到S100A8作為檢測T3+T4之口腔癌生物標誌。接下來使用西方墨點法、酵素免疫聯結吸附分析以及免疫組織染色進一步證實,S100A8在口腔癌晚期(T3和T4)的表現較高。根據AUROC曲線得知,在口腔癌唾液中S100A8有較高準確度,因此S100A8蛋白和口腔癌唾液為正相關。由此可知ZNF510胜肽以及S100A8蛋白可作為檢測口腔癌之生物標誌。
γ –Bisabolene可造成癌細胞粒線體膜電位下降,來活化caspase 3/9誘導口腔癌細胞凋亡。根據奈流液相層析質譜得到,正調控的磷酸化蛋白為p53、protein phosphatases 1 (PP1)以及ERK1/2,另外負調控蛋白為histone deacetylase 2 (HDAC2)。使用GeneGo MetaCore軟體得知,γ –Bisabolene可經由PP1-HDAC2-p53以及ERK1/2-p53路徑誘導細胞凋亡,γ –Bisabolene亦可增加p53的乙醯化以及調控細胞凋亡基因之表現。此外在γ–Bisabolene誘導Ca9-22以及SAS細胞凋亡中,加入PP1 inhibitor-2抑制劑會恢復HDAC2的磷酸化、降低p53的乙醯化以及PUMA mRNA的表現量。在γ–Bisabolene誘導Ca9-22以及SAS細胞凋亡中,加入MEK和ERK1/2抑制劑,也會抑制PUMA mRNA的表現量。根據上述結果得知,γ–Bisabolene經由粒線體、PP1-HDAC2-p53以及ERK1/2-p53路徑誘導細胞凋亡。動物實驗中,γ–Bisabolene亦可有效控制口腔癌細胞增生以及腫瘤縮小,可開發作為抗口腔癌之藥物。

Oral squamous cell carcinoma (OSCC) is a worldwide malignant that has emerging as a public health problem in Taiwan. Saliva is a non-invasive sample with good potential to investigate biomarkers for early diagnosis of oral cancer.
In our project, we collected saliva samples from 27 health controls and 106 OSCC patients during the period 2008-2012. Using C8-magnetic beads, MALDI-TOF MS technology and the ClinProTools software, we identified a peptide of zinc finger protein 510 (ZNF510) from a 2918.57 Da signal that distinguished OSCC patients from controls. Results from enzyme-linked immunosorbent assay (ELISA) and immuno-histochemical methods, we found ZNF510 peptide level was significantly increased in the saliva (P<0.001) and higher in the tissue sections of OSCC patients, in comparison with the health donors. The value of areas under receiver-operating characteristic (AUROC) curve of OSCC at stages T1+T2 was 0.95, indicating high level of accuracy for the ZNF510 peptide-based ELISA in detection of early stages of OSCC patients. By proteomic approaches, ZNF510 was identified as an oral cancer biomarker for early detection. In addition, analysis of low molecular weight salivary proteins (10 to 15 kDa) via the nanoLC-MS/MS method, we isolated the salivary S100A8 proteins as potential biomarkers in T3+T4 stages of OCSS, respectively. Results from western blotting, ELISA and immuno-histochemical methods, we found strongly up-regulation of S100A8 levels in late stage in saliva and tissues of OSCC. Importantly, salivary S100A8 protein was positively correlated to tumor size stage of OSCC, meanwhile the AUROC curve of S100A8-based ELISA exhibited high level of accuracy. Collectively, our data suggest that both ZNF510 and S100A8 are potential salivary biomarkers for the diagnosis of developing OSCC.
In our second project, we identified a cardamom-derived compound, γ-bisabolene, which possesses antiproliferative activities against of OSCC in vitro and in vivo. We found γ-bisabolene can lead to apoptosis of OSCC cell lines (Ca9-22 and SAS) by activating caspases-3/-9 as well as reducing mitochondrial membrane potential. Using nanoLC-MS/MS, western blotting and real-time RT-PCR methods to analyze the phosphoproteome profiling of γ -bisabolene-treated OSCC cells, results indicated the enrichment of phosphorylated ERK1/2, protein phosphatases 1 (PP1), and p53 and the reduction of phosphorylated histone deacetylase 2 (HDAC2) during apoptosis. In addition, by using Metacore GeneGo analysis, our results proposed the γ-bisabolene-induced apoptosis might involve in PP1-HDAC2-p53 and ERK1/2-p53 pathways. γ-bisabolene was found to enhance acetylation of p53 that increased the expression of p53-regulated apoptotic genes. PP1 inhibitor-2 increased the phosphorylation of HDAC2 and decreased acetylation of p53 and PUMA gene expression in γ-bisabolene treated Ca9-22 and SAS cells. ERK and MEK inhibitors reduced the expression of PUMA gene after treating Ca9-22 and SAS cells with γ-bisabolene. The results confirmed that the treatment of oral cancer cells with γ-bisabolene induced mitochondria-mediated apoptosis via PP1-HDAC2-p53 and ERK1/2-p53 signal pathways. Our study suggests that γ-bisabolene maybe a potential anti-tumor agent of human oral cancer.
URI: http://hdl.handle.net/11455/92190
Rights: 同意授權瀏覽/列印電子全文服務,2018-08-11起公開。
Appears in Collections:生物化學研究所

Files in This Item:
File SizeFormat Existing users please Login
nchu-104-8098058002-1.pdf7.85 MBAdobe PDFThis file is only available in the university internal network    Request a copy
Show full item record
 
TAIR Related Article

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.